Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children

Last updated on July 2021

Recruitment

Recruitment Status: Active, not recruiting
Estimated Enrollment: 21000

Summary

Conditions

Children
Measles Vaccination
Morbidity
Mortality
Non-specific/Heterologous Effects of Vaccines
Oral Polio Vaccine

Type

Interventional

Phase

Phase 4

Design

Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: The RECAMP trials test two separate hypotheses relating to the potential beneficial non-specific effects of providing live vaccines in general vaccination campaigns. The RECAMP-MV trial tests the effect of a Measles Vaccination campaign among children aged 9-59 months The RECAMP-OPV trial tests the effect of an Oral Polio Vaccination campaign in children aged 0-8 monthsMasking: Single (Care Provider)Primary Purpose: Prevention

Participation Requirements

Age: Younger than 59 years
Gender: Both males and females

Description

Not Provided

Tracking Information

NCT #

NCT03460002

Collaborators

Statens Serum Institut
Research Center for Vitamins and Vaccines

Investigators

Principal Investigator: Ane Fisker, MD, PhD Bandim Health Project, Guinea-Bissau and Statens Serum Institute, Research Center for Vitamins and Vaccines, Bandim Health Project Principal Investigator: Peter Aaby, DMSc,Professor Bandim Health Project, Guinea-Bissau and Statens Serum Institute, Research Center for Vitamins and Vaccines, Bandim Health Project Principal Investigator: Aksel Jensen, PhD Statens Serum Institute, Research Center for Vitamins and Vaccines, Bandim Health Project Principal Investigator: Anshu Varma, MSc Statens Serum Institute, Research Center for Vitamins and Vaccines, Bandim Health Project Principal Investigator: Amabelia Rodrigues, Ph Bandim Health Project, Guinea-Bissau